Pathomorphological studies and study of tumors

Home
Dobrobut laboratory
Pathomorphological studies and study of tumors

Histological tests

Oncological cytogenetics

Immunohistochemical tests

Molecular diagnostics of tissues and samples

Title	Price (uah)
HER-2 / neu gene amplification (in situ hybridization, DAKO HER-2 CISH pharmDx set) in mammary gland and stomach tumors	12000
Methylation of the MLH1 gene promoter for the differential diagnosis of sporadic and hereditary microsatellite instability	2200
Molecular genetic examination: panel for diagnostics of thyroid cancer mutations BRAF, NRAS, KRAS, NRAS, RET / PTC1, RET / PTC3, PAX8 / PPARg (punctate)	3200
Determination of AML1-ETO by PCR	3100
Determination of BCR-ABL1 (p190) (Philadelphia chromosome) by PCR method	3300
Determination of BCR-ABL1 (p210) (Philadelphia chromosome) by PCR method	3600
Determination of BRAF V600 by PCR (CM material or peripheral blood)	3400
Determination of CBFβ-MYH11 by PCR	3100
Determination of E2A-PBX1 by PCR	3100
Determination of JAK2 (V617F) by PCR	3300
Determination of MLL-AF4 by PCR	3100
Determination of PML-RARα by PCR method	3300
Determination of RUNX1-RUNX1T1 by PCR	3100
Determination of TEL-AML1 by PCR	3100
EGFR Mutations, PCR	5800
Determination of DNA mismatch repair proteins (microsatellite stability/instability of the tumor)	2500
Histological examination to determine BRAF V600 by PCR	5800
Histological examination for the determination of Helicobacter pylori	1650
OncoMine - Laboratory tests for molecular cancer profiling	104000
OncoTarget BRCA1/2 Somatic - from tumor tissue by NGS	12800
OncoTarget Complete - diagnostics of DNA somatic mutations and RNA translocations, NGS	33400
OncoTarget DNA - Laboratory studies on profiling of somatic mutations (65 NGS genes)	20450
OncoTarget HRR - HRR panel (12 genes)	17300
OncoTarget RNA - Laboratory studies of translocations in 13 genes, NGS method	23199
Epstein-Barr virus DNA (EBV) (CISH)	2200
Quantitative determination of the leukemia marker BCR-ABL1 p210, PCR	6900
Quantification of BCR-ABL1 p190 translocation by PCR	4300
Quantification of PML-RARA t(15;17) translocation by PCR	7900
Molecular-genetic study of thyroid punctate	1900
Determination of JAK2 (V617F), 14 exon, PCR	3300
Definition of RAS (KRAS, NRAS, HRAS) by PCR (histological material)	9000
CALR mutations, PCR	4200
FLT3 (D835Y) mutations, PCR	3400
IDH 1/2 mutations, PCR	5500
MPL mutations (W515A/L/K/R), PCR	4200
NPM1 mutations (MutA,B,C&D), PCR	4200
PIK3CA mutations, PCR	6300
Determination of JAK2, 12 exon, PCR	4100
Acute promyelocytic leukemia M3 (monitoring of MRD, PML RARa, PCR)	7500
Panel for gastrointestinal stromal tumors (GIST: KIT and PDGFRα mutations), PCR	8800
NTRK1/2/3 translocations, PCR	7900
Chronic myeloid leukemia (MRD monitoring, BCR-ABL, PCR)	6900

TitlePrice (uah)

HER-2 / neu gene amplification (in situ hybridization, DAKO HER-2 CISH pharmDx set) in mammary gland and stomach tumors

12000 uah

Methylation of the MLH1 gene promoter for the differential diagnosis of sporadic and hereditary microsatellite instability

2200 uah

Molecular genetic examination: panel for diagnostics of thyroid cancer mutations BRAF, NRAS, KRAS, NRAS, RET / PTC1, RET / PTC3, PAX8 / PPARg (punctate)

3200 uah

Determination of AML1-ETO by PCR

3100 uah

Determination of BCR-ABL1 (p190) (Philadelphia chromosome) by PCR method

3300 uah

Determination of BCR-ABL1 (p210) (Philadelphia chromosome) by PCR method

3600 uah

Determination of BRAF V600 by PCR (CM material or peripheral blood)

3400 uah

Determination of CBFβ-MYH11 by PCR

3100 uah

Determination of E2A-PBX1 by PCR

3100 uah

Determination of JAK2 (V617F) by PCR

3300 uah

Determination of MLL-AF4 by PCR

3100 uah

Determination of PML-RARα by PCR method

3300 uah

Determination of RUNX1-RUNX1T1 by PCR

3100 uah

Determination of TEL-AML1 by PCR

3100 uah

EGFR Mutations, PCR

5800 uah

Determination of DNA mismatch repair proteins (microsatellite stability/instability of the tumor)

2500 uah

Histological examination to determine BRAF V600 by PCR

5800 uah

Histological examination for the determination of Helicobacter pylori

1650 uah

OncoMine - Laboratory tests for molecular cancer profiling

104000 uah

OncoTarget BRCA1/2 Somatic - from tumor tissue by NGS

12800 uah

OncoTarget Complete - diagnostics of DNA somatic mutations and RNA translocations, NGS

33400 uah

OncoTarget DNA - Laboratory studies on profiling of somatic mutations (65 NGS genes)

20450 uah

OncoTarget HRR - HRR panel (12 genes)

17300 uah

OncoTarget RNA - Laboratory studies of translocations in 13 genes, NGS method

23199 uah

Epstein-Barr virus DNA (EBV) (CISH)

2200 uah

Quantitative determination of the leukemia marker BCR-ABL1 p210, PCR

6900 uah

Quantification of BCR-ABL1 p190 translocation by PCR

4300 uah

Quantification of PML-RARA t(15;17) translocation by PCR

7900 uah

Molecular-genetic study of thyroid punctate

1900 uah

Determination of JAK2 (V617F), 14 exon, PCR

3300 uah

Definition of RAS (KRAS, NRAS, HRAS) by PCR (histological material)

9000 uah

CALR mutations, PCR

4200 uah

FLT3 (D835Y) mutations, PCR

3400 uah

IDH 1/2 mutations, PCR

5500 uah

MPL mutations (W515A/L/K/R), PCR

4200 uah

NPM1 mutations (MutA,B,C&D), PCR

4200 uah

PIK3CA mutations, PCR

6300 uah

Determination of JAK2, 12 exon, PCR

4100 uah

Acute promyelocytic leukemia M3 (monitoring of MRD, PML RARa, PCR)

7500 uah

Panel for gastrointestinal stromal tumors (GIST: KIT and PDGFRα mutations), PCR

8800 uah

NTRK1/2/3 translocations, PCR

7900 uah

Chronic myeloid leukemia (MRD monitoring, BCR-ABL, PCR)

6900 uah

Drug counseling

General clinical studies

Immunohematological tests

Biochemical tests

Complex tests

Hormone tests

Pregnancy and prenatal screening

Immunological and autoimmune tests

Infections

Microbiological studies

Cytological tests

Genetic tests

Pathomorphological studies and study of tumors

Useful information

News

View all

"Dobrobut" Paid 578 Million UAH in Taxes in 2024

The medical network "Dobrobut" paid nearly 578 million UAH in taxes in 2024. The network's revenue for the year amounted to 3.5 billion UAH, which is 52% higher than in 2023. The plan for 2025 is to increase this figure by at least one-third.

"Dobrobut" Provides Free Innovative Treatment for Crohn's Disease

The medical network "Dobrobut" has launched its first international clinical trial to evaluate the efficacy of a new drug for Crohn's disease treatment. The investigational drug has been approved by the State Expert Center of the Ministry of Health of Ukraine. The project is led by the network’s chief gastroenterologist, internal medicine specialist Ruslan Buyanovskyi.

Dobrobut launches cytogenetic laboratory

The medical network "Dobrobut" has launched its own cytogenetic laboratory. From now on, the full range of tests for determining the karyotype – the human chromosome set – will be performed by "Dobrobut's" own geneticists.

Articles

View all

Testing by PCR

Dobrobut Medical Network — is the first in Ukraine network of private clinics with a full range of medical services for children and adults. 16 clinics of the network are conveniently located in Kyiv. In view of COVID-19 pandemic in Ukraine, and in the whole world, Dobrobut offers testing by

Bacteriological culture, its significance. How to properly do bakposev

Bakposiv from the cervical canal and its other types Microorganisms (bacteria, viruses, protozoa and others) accompany a person throughout his life. The question of the presence of infection is especially important for children, women, the elderly and weakened people. What microorganisms should be f